EFPIA Newsletter 16 June 2022

EFPIA-EURORDIS Joint statement on Patient Access to Medicines for Rare Diseases     Learn more on efpia.eu   This weeks marks the publication of the EFPIA-EURORDIS Joint statement on Patient Access to Medicines for Rare Diseases. The statement is based on an 18-month structured dialogue between the two organisations focused on identifying proposals that can improve access to orphan medicines across Europe. At the same time the statement recognises areas where the two organisations have different perspectives. Read more →

News     16 June 2022 European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer... Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve... Read more →

Blogs     14 June 2022 World innovation from Slovenia Frida humanoid robot to be tested in a hospital environment Read more →

Events     23 JUN 2022   EPF Congress 2022 – Continuing the conversation on digital transformation DoubleTree by Hilton, Brussels & Online You are invited. Learn more →       27 JUN 2022   11th European Conference on Rare Diseases & Orphan Products Virtual event Putting rare diseases policy into action. Learn more →

	28 JUN 2022			Meeting the Diabetes Challenge Hybrid event The Role of Digital Tools, Data Registries, and Integrated Care in Improving Lives and Outcomes for People with Diabetes... Learn more →

	29 JUN 2022			From Crisis to Catalyst: Build resilience, back innovation and boost access Concert Noble, Brussels, & Online You are invited to EFPIA 2022 Conference. Learn more →

What we are reading Push to revamp rare disease EU framework intensifies before Czech presidency 15 June 2022  (Euractiv) Read more → The time is now: How to restore Europe’s leading position in pharma innovation 25 May 2022  (Politico) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe